Veru Inc.

Stage 2 · Advancing · week 2

As of Oct 22, 2026, Veru is in Stage 2, the uptrend phase, now in week 2 (since Oct 12, 2026). It closed at $2.29, 45.9% below its 52-week high and below its 200-day average, which is rising.

$2.29

-0.43% today

$39.0M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 110 in Biotechnology · #1 of 272 in Health Care

Is VERU early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 15w

S3 13w

S4 17w

S4 15w

S4 29w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S1 1w → S4 15w → S1 4w → S4 12w → S1 4w → S2 8w → S3 13w → S4 17w → S1 3w → S4 15w → S1 10w → S4 29w → S1 4w → S4 9w → S1 5w → S2 5w → S3 4w → S4 1w → S3 2w → S2 2w current

Total tracked: 164 weeks across 20 stage runs.

VERU among Biotechnology339th of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…339	VERUVeru Inc.	Stage 2 · wk 2	25	−6.9%

vs 52W High

-45.9%

$2.09 lo$4.23 hi

45.9% below 52W high

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 2

1w13w26w

Week 2, fresh breakout

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

-8.4%

200 DMA: $2.50 · rising

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

0.42x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-6.9%

+1.8%

-0.9%

YTD

+0.9%

-46.7%

Scan Membership

Breakout Watch

Latest: 2024-04-30

6 appearances in last 60 days. First seen: 2019-05-29.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S2

Wk 2 · Vol 0.42x

2026-10-21S2

Wk 2 · Vol 0.44x

2026-10-20S2

Wk 2 · Vol 0.37x

2026-10-19S2

Wk 2 · Vol 0.36x

2026-10-16S2

Wk 1 · Vol 1.25x

2026-10-15S2

Wk 1 · Vol 2.13x

2026-10-14S2

Wk 1 · Vol 1.16x

2026-10-13S2

Wk 1 · Vol 0.71x

2026-10-12S23→2

Wk 1 · Vol 0.36x

2026-10-09S3

Wk 3 · Vol 0.54x

2026-10-08S3

Wk 2 · Vol 0.61x

2026-10-07S3

Wk 2 · Vol 0.84x

Moving averages & range

50 DMA

$2.51

200 DMA

$2.50

52W High

$4.23

52W Low

$2.09

5D Low

$2.29

Resistance levels (recent highs)

20d High

$2.66

60d High

$2.80

120d High

$4.23

250d High

$4.23

Next resistance

+16.2%

to 20d High

ROE

-64.5%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 1.4

Veru: quick answers

What stage is Veru in?

As of Oct 22, 2026, Veru (VERU) is in Stage 2, the uptrend phase. It entered Stage 2 on Oct 12, 2026 and is in week 2. What the four stages mean

Is Veru in an uptrend?

Yes. Veru is in a Stage 2 uptrend. It trades 8.4% below its 200-day average, which is rising.

How far is Veru from its 52-week high?

Veru closed at $2.29 on Oct 22, 2026, 45.9% below its 52-week high of $4.23. Its 52-week low is $2.09.

How has Veru performed over the past year?

As of Oct 22, 2026, Veru is down 46.7% over the past year and up 0.9% so far in 2026.

Which sector and industry is Veru in?

Veru is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.